Unveiling the development principles and mechanistic understanding of controlled drug delivery strategies for chronic bone defects and diabetic wound management

Abstract

Hydrogel and ferrogel-based systems are leading the way in therapeutic approaches for treating diabetes-related complications, such as bone abnormalities and impaired wound healing. As a desirable multipurpose material, transition metal oxides (TMO) are receiving more interest in biological applications. The doping of TMOs inside the polymer network is the focus of the present review, which also covers the basic ideas and important capabilities of hydrogels and ferrogels. Notably, the use of DNA engineering and nanotechnology in hydrogel frameworks has greatly advanced their functioning by allowing for precise and regulated release mechanisms. This review highlights the significant influence of TMO-grafted hydrogels on regulating the immune system, reducing inflammation, promoting angiogenesis, and supporting osteogenic differentiation, all of which excellently aid in wound healing and bone repair in diabetic circumstances. The combination of these characteristics attributes how hydrogel drug-loading devices can revolutionize tissue repair and diabetic treatment approaches, and usher in a new age of improved, customized healthcare solutions. This review offers a thorough depiction of the diverse spectrum of projections over hydrogels to provide readers with a clear grasp of the most recent advancements, traits, history, and applications of hydrogels and ferrogels.

Graphical abstract: Unveiling the development principles and mechanistic understanding of controlled drug delivery strategies for chronic bone defects and diabetic wound management

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Review Article
Submitted
15 May 2025
Accepted
13 Jul 2025
First published
14 Jul 2025
This article is Open Access
Creative Commons BY-NC license

Mater. Adv., 2025, Advance Article

Unveiling the development principles and mechanistic understanding of controlled drug delivery strategies for chronic bone defects and diabetic wound management

S. Awasthi, Mater. Adv., 2025, Advance Article , DOI: 10.1039/D5MA00490J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements